- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06272331
Milk and Plant Protein Digestion (MAPP-D)
Postprandial Amino Acid Profiles and Gastric Protein Coagulation After Consumption of Milk and Plant-based Alternatives: an Exploratory Study
The goal of this study is to explore the effect of protein quantity and quality in plant-based drinks. Healthy normal-weight males aged between 18 and 45 years will be included in the study.
The main objectives are to examine the differences in postprandial amino acid profiles, and to examine differences in gastric behavior between cow's milk and plant based drinks.
Participants will visit after an overnight fast three times and have blood draws before and after consumption one of the study drinks. There will be MRI scans of the stomach before and after consumption of the drink to assess gastric behavior.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Rationale: There is a growing interest in plant-based alternatives for bovine milk. However, these plant-based drinks are not a complete nutritional substitute for bovine milk, especially when focusing on the protein content and quality of these products. Knowledge on the effects of protein quantity and quality of plant based drinks on postprandial plasma responses and gastric behavior compared to bovine milk is lacking.
Objective: To explore the effect of protein quantity and quality of protein in plant-based drinks. In addition, gastric behavior will be examined and compared to that of bovine milk.
Study design: Single-blind randomized cross-over study with three treatments.
Study population: 12 healthy normal-weight males, aged 18-45 y.
Intervention: After an overnight fast, participants will drink cow's milk, or a plant-based drink. Gastric behavior will be monitored using Magnetic Resonance Imaging (MRI). Blood samples will be collected for plasma metabolomic analyses. In addition, wellbeing will be assessed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Wageningen, Netherlands, 6708WE
- Human Research Unit - Division of Human Nutrition and Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male
- Age 18 - 45 y
- Apparently healthy (self-reported)
- Normal-weight (BMI 18.5 - 25 kg/m2)
- Willing to be informed about incidental findings of pathology
- Willing to comply with the study procedures
Exclusion Criteria:
- Allergy or intolerance for cow milk, lactose or gluten (self-reported)
- Gastric disorders or regular gastric complaints, for example heart burn
Use of medication which alters the normal functioning of the stomach, such as:
- Medical drug use that influences the GI tract's normal function, e.g. motility, pH etc.: among others use of protein pump inhibitors, antacids, anti-depressants etc. (judged by study doctor)
- Medical drug use that influences the GI tract's microbiota: antibiotic use within one month prior to the pre-study screening day (judged by study doctor)
- Following a vegan diet
- Smoking (>2 cigarettes a week)
- Having a chronic illness that could affect food digestion and nutrient absorption including but not limited to kidney disease, thyroid disease and diabetes mellitus (self-reported)
- Alcohol consumption of more than 14 glasses/week
- Having given a blood donation in the past two months
- Hb value below 8.5 mmol/L (as measured with finger-prick method at screening)
Having a contra-indication to MRI scanning, including, but not limited to:
- Pacemakers and defibrillators
- Intraorbital or intraocular metallic fragments
- Ferromagnetic implants
- Claustrophobia
- Participating in other research during the study period
- Not having a general practitioner
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Low-protein plant-based drink
Ingestion of a low-protein plant-based drink.
|
Ingestion of a low-protein plant-based drink
|
|
Other: High-protein plant-based drink
Ingestion of a high-protein plant-based drink
|
Ingestion of a high-protein plant-based drink
|
|
Other: Cow's milk
Ingestion of cow's milk.
|
Ingestion of cow's milk
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial plasma amino acid profile as characterized by the peak height and iAUC
Time Frame: 5 hours
|
Change in postprandial plasma amino acid profile over time
|
5 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastric behavior
Time Frame: 2 hours
|
Change in gastric behavior over time as determined from an abdominal MRI scan
|
2 hours
|
|
Postprandial plasma response
Time Frame: 5 hours
|
Change in postprandial plasma response from baseline over time
|
5 hours
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Verbal ratings of wellbeing
Time Frame: 5 hours
|
Change in wellbeing from baseline over time on a 100-point scale
|
5 hours
|
|
MRI markers of digestion
Time Frame: 2 hours
|
Change in Magnetization Transfer ratio from baseline over time
|
2 hours
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Paul Smeets, PhD, Wageningen University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NL83162.091.22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Digestion
-
Deerland EnzymesKennesaw State UniversityRecruitingSatiety | Indigestion | Digestive Health | Protein Digestion | Carbohydrate Digestion | Fat DigestionUnited States
-
Wageningen UniversityCompleted
-
Newcastle UniversityCompletedTriacylglycerol DigestionUnited Kingdom
-
DSM Food SpecialtiesCompleted
-
Efforia, IncActive, not recruiting
-
Maastricht University Medical CenterFrieslandCampinaCompletedProtein Digestion & AbsorptionNetherlands
-
NestléCompletedHappiness | Digestion | TemperamentChina
-
NIZO Food ResearchFrieslandCampinaCompleted
Clinical Trials on Low-protein plant-based drink
-
Taipei Veterans General Hospital, TaiwanRecruiting
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
Atlantia Food Clinical TrialsTerminated
-
Anglia Ruskin UniversityDanone Nutricia ResearchCompletedGastrointestinal Dysfunction | Amino Acid ChangeUnited Kingdom
-
Barbara Jakše s.p.CompletedObesity | Weight Loss
-
Radboud University Medical CenterMaastricht University Medical Center; Fresenius KabiRecruitingRisk of MalnutritionNetherlands
-
Danone North AmericaCompletedHealthy Resistance-Trained MalesCanada
-
Unilever R&DCompleted
-
University of JenaGerman Federal Ministry of Education and ResearchCompleted